117 related articles for article (PubMed ID: 20057413)
1. Drug ads move online, creating a web of regulatory challenges.
Wadman M
Nat Med; 2010 Jan; 16(1):22. PubMed ID: 20057413
[No Abstract] [Full Text] [Related]
2. US aims to tighten rules on direct-to-consumer drug ads.
Vastag B
Nat Biotechnol; 2007 Mar; 25(3):267. PubMed ID: 17344868
[No Abstract] [Full Text] [Related]
3. Legal issues concerning the promotion of pharmaceutical products on the internet to consumers.
Reichertz PS
Food Drug Law J; 1996; 51(3):355-65. PubMed ID: 11797712
[No Abstract] [Full Text] [Related]
4. Dealing with drug advertising. The FDA can't always enforce the rules on misleading ads.
Atkinson HG
Health News; 2003 Feb; 9(2):5. PubMed ID: 12632541
[No Abstract] [Full Text] [Related]
5. Free rein for drug ads? A slowdown in FDA review has left consumers more vulnerable to misleading messages.
Consum Rep; 2003 Feb; 68(2):33-7. PubMed ID: 12516586
[No Abstract] [Full Text] [Related]
6. The new drug marketing: a consumer protection perspective.
Woodward D
Food Drug Law J; 1996; 51(4):637-50. PubMed ID: 11797733
[No Abstract] [Full Text] [Related]
7. The regulation of prescription drug advertising.
Rheinstein RH; Hugstad PS
Leg Med Annu; 1978; ():407-19. PubMed ID: 756944
[No Abstract] [Full Text] [Related]
8. Medicine goes Madison Avenue: an evaluation of the effect of direct-to-consumer pharmaceutical advertising on the learned intermediary doctrine.
Allen MC
Spec Law Dig Health Care Law; 1998 Dec; (236):9-29. PubMed ID: 10187553
[No Abstract] [Full Text] [Related]
9. Legal overview of likely FDA regulation of Internet promotion.
Scheineson MJ
Food Drug Law J; 1996; 51(4):697-716. PubMed ID: 11797736
[No Abstract] [Full Text] [Related]
10. Prescription drug advertising--should states regulate what is false and misleading?
Shaeffer J
Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454
[No Abstract] [Full Text] [Related]
11. A defense of the learned intermediary doctrine.
Goetz RB; Growdon KR
Food Drug Law J; 2008; 63(2):421-38. PubMed ID: 18561470
[No Abstract] [Full Text] [Related]
12. The FDA's restrictions against prescription drug advertising: more hindrance than help.
Lorman AJ
Healthspan; 1991 Nov; 8(10):3-7. PubMed ID: 10114942
[No Abstract] [Full Text] [Related]
13. Regulation of cosmetics that are also drugs.
Greff JA
Food Drug Law J; 1996; 51(2):243-72. PubMed ID: 11820201
[No Abstract] [Full Text] [Related]
14. Understanding government regulation of the marketing and advertising of medical devices, drugs, and biologics: the challenges of the Internet.
Reichertz PS
Food Drug Law J; 1997; 52(3):303-8. PubMed ID: 10343029
[No Abstract] [Full Text] [Related]
15. FDA weighs limits for online ads.
Kuehn BM
JAMA; 2010 Jan; 303(4):311-3. PubMed ID: 20103748
[No Abstract] [Full Text] [Related]
16. The promise and peril of direct-to-consumer prescription drug promotion on the Internet.
Hall TS
DePaul J Health Care Law; 2003; 7(1):1-41. PubMed ID: 15468476
[No Abstract] [Full Text] [Related]
17. Anticipating new consumer protection challenges in the food and drug marketplace.
Parnes LB
Food Drug Law J; 2008; 63(2):593-9. PubMed ID: 18561480
[No Abstract] [Full Text] [Related]
18. US Congress to consider limits on DTCA.
Guthrie P
CMAJ; 2007 May; 176(10):1404. PubMed ID: 17485685
[No Abstract] [Full Text] [Related]
19. Ambiguities of the Dietary Supplement Health and Education Act of 1994.
Pinco RG; Rubin PD
Food Drug Law J; 1996; 51(3):383-405. PubMed ID: 11797716
[No Abstract] [Full Text] [Related]
20. Plugs for drugs.
Masson A; Rubin PH
Regulation; 1986; 10(1):37-43, 53. PubMed ID: 10280556
[No Abstract] [Full Text] [Related]
[Next] [New Search]
